Endometriosis Pain Control Wants to Suppress Ovulation — She Wants to Conceive Next Year
Hormonal suppression is genuinely controlling her endometriosis pain — and genuinely working against the fertility timeline she's set for next year, since the same mechanism does both.
Grace N., a 33-year-old woman, has managed a nonprofit's grant-writing office for the past five years, work she's had to schedule around a pelvic pain that has been part of her life since her early twenties, laparoscopically confirmed as stage II endometriosis three years ago. A combined OCP, continuous rather than cyclic, has genuinely reduced her pain from what she rates as an 8 out of 10 during flares down to a manageable 3, and she's stayed on it for two years without needing further intervention. What's changed since her last visit is that she and her partner have set a concrete timeline — they want to start trying to conceive within the next year, a plan the current medication works directly against, since the same ovulation suppression controlling her pain also prevents the pregnancy she now wants.
The tension isn't really between "more medication" and "surgery" in the abstract — it's that every hormonal option genuinely available for endometriosis pain, from her current OCP to a GnRH antagonist like elagolix, works substantially through the same ovulation-suppressing mechanism, which is precisely what she now needs to not happen. Surgical excision is the one option that addresses the anatomic disease directly without asking her ovaries to stay quiet indefinitely — but ASRM's own staged evidence on whether excision meaningfully improves fertility outcomes is more consistent for moderate-to-severe, anatomically distorting disease than for milder presentations, and her stage II diagnosis, three years old, hasn't been re-imaged or re-staged since. That gap is the real fork in the decision: if three years of unmonitored progression have pushed her toward the moderate-to-severe end of the spectrum, ASRM's own evidence argues for excision before she spends another year on a medication that cannot touch the anatomy; if she has genuinely stayed stage II, the calculus tips back toward finding her an ovulation-permissive bridge instead. What three-year-old staging cannot distinguish is exactly this: deep infiltrating disease or endometriomas would push her toward the surgical evidence base, while superficial peritoneal implants alone would not, and nothing in her chart says which one she actually has today — a gap a single re-imaging visit would close before either path gets chosen blind.
Consult, fertility timeline just declared
Her pain is genuinely controlled right now, and that's not nothing — an 8 down to a 3 over two stable years is a real, working regimen. Surgery carries its own real morbidity: anesthesia risk, adhesion formation, a recovery period she doesn't currently need if pain is the only variable being optimized. I'd want a clear reason beyond "she wants to conceive" before recommending a laparoscopy she isn't otherwise indicated for.
If she weren't trying to conceive at all, I don't think this is a close call — continued medical management would clearly be the right answer.
But she is trying to conceive, and that's the whole reason this visit is happening. Every hormonal option that controls her pain does it substantially through ovulation suppression — continuing the OCP, or stepping up to elagolix, both work directly against the timeline she's set. "Controlled" can't just mean pain score anymore; it has to mean controlled without preventing the thing she's now asking for.
I'm not dismissing the surgical morbidity concern — I'm saying the calculus changes once conception is an active goal, because the alternative isn't "stay on a working drug," it's "stay on a drug that specifically blocks what she wants for the next several months while she tries to time a fertility window around it."
Before either of you recommends a path, her actual disease stage needs updating — three years is long enough for real progression, and the surgical-fertility evidence itself isn't uniform. ASRM's staged data supports excision meaningfully improving spontaneous conception odds in moderate-to-severe, anatomically distorting disease; for milder disease without distortion, the fertility benefit is less consistently shown, and surgery's case rests more on pain control than fertility in that scenario. We don't actually know which category she's in right now.
Agreed: diagnostic laparoscopy with re-staging, with excision performed at the same procedure if moderate-to-severe distorting disease is confirmed, continuing her current OCP as a bridge until then. If re-staging shows only mild, non- distorting disease, the plan reverts to discontinuing the OCP and attempting conception directly, since surgery's fertility benefit in that scenario is less established. All three positions converged once the actual disease stage was recognized as the missing, decision-directing piece of information — the pain-versus-fertility framing that opened the debate turned out to be a proxy for a question surgery itself will answer.